Samina Hamied

Creating an innovation hub for the global healthcare sector

A third-generation heir to Cipla and a fitness enthusiast, Samina Hamied is a marathon runner both in the business world and on the track. The Executive Vice-Chairperson at Cipla, Samina, envisions a future where Cipla is not just a leader in the field of generics but also a hub of R&D and innovation in healthcare.

Having worked in the UK and the US with leading global firm Goldman Sachs, Samina joined the leadership team of Cipla in 2011 and took over as Executive Vice Chairperson in 2016. The company leapfrogged into the top 10 generics players by prescription with a 2.3% market share. Samina has also played an integral role in successfully incubating and shaping Cipla Health Ltd .

A company, established over eight decades ago, became a global brand when Samina steered it into new markets and product segments. She made Cipla a known entity in the US market with strategic acquisitions. She is now steering Cipla’s ascension up the healthcare value chain to be a major global healthcare organization underpinned by innovation and digital transformation. The company is poised to create innovative, digitally driven medical solutions armed with deep patient insights, scientific knowledge and expertise combined with a legacy of care.

A post-graduate from the London School of Economics and Political Science, Samina firmly believes in inclusive and sustainable growth and is focused on building a workplace that is truly progressive on all fronts – right from pursuing a meaningful larger purpose and creating a culture of meritocracy and inclusion, to continuously equipping its talent with new-age leadership skills for growth. Cipla’s humanitarian approach to healthcare in pursuit of its purpose of “Caring for Life” resonates with Samina’s guiding force that people are the foundation of Cipla.